Title: Pedro M Alzari - Innovator in Neurotrophin Research
Introduction
Pedro M Alzari is an inventor based in Paris, France. He has made significant contributions to the field of neurotrophin research. Although he currently holds no granted patents, his work has the potential to impact the treatment of chronic pain and neuron loss.
Latest Patent Applications
Pedro M Alzari's latest patent application is titled "Post-Translationally Modified Neurotrophins." This invention describes how neurotrophins undergo post-translational modifications, which mediate their pro-apoptotic and/or pro-neurite activity. The modifications include nitration and the formation of conformationally different dimers, as well as abnormal oligomers such as tetramers and octamers. The invention also relates to compounds that compete with these modified neurotrophins and those that bind to them. This research provides useful agents for treating conditions involving chronic pain and neuron loss.
Conclusion
Pedro M Alzari's innovative work in neurotrophin research highlights the importance of understanding post-translational modifications in developing therapeutic agents. His contributions may pave the way for advancements in treating neurological conditions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.